Stock CTXR CITIUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Citius Pharmaceuticals, Inc.

Equities

CTXR

US17322U2078

Market Closed - Nasdaq
Other stock markets
 21:00:00 01/07/2024 BST 		5-day change 1st Jan Change
0.5433 USD -6.92% Intraday chart for Citius Pharmaceuticals, Inc. -14.78% -28.18%
05-21 Citius Pharmaceuticals, Inc. Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution CI
05-14 Citius Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Citius Pharmaceuticals Price Target to $4 From $6, Maintains Buy Rating
MT
HC Wainwright Adjusts Citius Pharmaceuticals Price Target to $6 From $4, Maintains Buy Rating
MT
Maxim Group Initiates Coverage on Citius Pharmaceuticals With Buy Rating, $4 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTXR Stock
  4. News Citius Pharmaceuticals, Inc.
  5. Analyst Reco.